Arrowhead Buys RNAi Research and Development Assets From Novartis
socalTECH
MARCH 5, 2015
Pasadena-based Arrowhead Research said this morning that it has acquired the entire RNAI research and development portfolio and associated assets of Novartis. Arrowhead will also gain a number of patents and patent applications related to the RNAi technology. READ MORE>>.
Let's personalize your content